Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates

Regulus Therapeutics (RGLS) Reports In-Line Q4 EPS

March 10, 2022 4:26 PM EST

Regulus Therapeutics (NASDAQ: RGLS) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.

... More